Career Development Program

职业发展奖将用于支持翻译胰腺的职业发展 由下列类别之一的个人进行的癌症研究： 1)内科肿瘤学、胃肠病学、病理学或外科临床研究员； 2)讲师或助理教授级别的初级教员，或寻求培训的临床教员 以及建立包括基础科学研究或基础科学教职员工在内的职业生涯的机会 需要额外的培训或从事翻译研究的机会； 3)即将进入学术行列并建立 自主研究项目； 4)需要在基础研究或翻译研究方面进行额外培训的现有临床教员 建立翻译研究计划。 我们每年资助一名新候选人，为期两年，每年资助87,500元。 (总计175,000美元)，每个奖项。每年75,000美元将由UNMC Eppley提供的等额资金提供 癌症中心，孢子计划将提供10万美元，因此每年总计高达175,000美元 可用于此计划。参加该计划的个人必须做出重大努力(至少 40%和更高百分比的努力受到强烈鼓励，并将获得优先选择) 相关翻译研究。资金可用于工资或任何其他方面的发展(研究 成本)，这些成本被认为是候选人成功建立翻译胰腺所必需的 癌症研究计划。候选人被要求在以下时间提交NIH G或R系列拨款申请 该奖项的第二年，主要集中在胰腺癌的研究上。

Career Development Awards will be used to support the development of careers in translational pancreatic cancer research by individuals from one of the following categories: 1) clinical fellows in medical oncology, gastroenterology, pathology, or surgery; 2) junior faculty members at the instructor or assistant professor level, either clinical faculty who seek training and an opportunity to establish a career that includes basic science research, or basic science faculty who want additional training or an opportunity to undertake translational research; 3) senior postdoctoral fellows who are at the point of entering the academic ranks and establishing independent research programs; 4) established clinical faculty who require additional training in basic or translational research in order to establish a translational research program. We will support one new candidate in each year of the grant at a level of $87,500 per year for two years ($175,000 total) for each award. $75,000 per year will be provided by matching funds from the UNMC Eppley Cancer Center, and $100,000 will be provided by the SPORE program, so that up to $175,000 total per year is available for this program. Individuals in this program are required to commit substantial effort (a minimum of 40%, and higher percent efforts are strongly encouraged and will receive preferential selection) to SPORE related translational research. Funds can be used for salaries or any other aspect of development (research costs) that are deemed necessary for the candidate to succeed in establishing a translational pancreatic cancer research program. The candidate is required to submit an NIH G or R series grant application during the second year of the award, that is primarily focused on pancreatic cancer research.